Observational studyBMC cancer2025

Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myeloma.

Luqun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.